TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price objective on shares of TRACON Pharmaceuticals in a research report on Monday, November […]

Related Keywords

United States , ,Pharmaceuticals Daily ,Susquehanna International Group ,Pharmaceuticals Inc ,Pharmaceuticals Price Performance ,Ci Private Wealth ,Pharmaceuticals Company Profile ,York Mellon Corp ,Renaissance Technologies ,Millennium Management ,Free Report ,Get Free Report ,New York Mellon Corp ,Tracon Pharmaceuticals ,Nasdaq Tcon ,Ltcon ,Medical ,Initiated Coverage ,Stocknews Com ,